BIO-TECHNE Corp (TECH) stock price, news and key stats

Price

Last close as of Sep 16, 2026. Delayed data; not a live quote.

Previous close

$72.34

Open

$72.35

Day range

$72.22 – $72.36

Volume

3.7M

About BIO-TECHNE Corp

Latest TECH news

• Minnesota companies on pace for record year in acquisition deals
  IPO & M&A · Aug 28, 2026

  Minnesota companies are on track for a record year in acquisition deals, driven by a notable surge in mega-deals, including Bio-Techne's recent $11.3 billion acquisition by Merck. This transaction not only underscores the growing appetite for consolidation within the biotechnology sector but also positions Minnesota as a key player in the national M&A landscape. The state's robust life sciences industry, combined with favorable market conditions, has created an environment ripe for significant corporate transactions. The uptick in acquisition activity is reflective of broader trends in the market, where companies are increasingly seeking to enhance their competitive edge through strategic mergers and acquisitions. Analysts suggest that the ongoing interest from larger firms in acquiring innovative companies is likely to continue, potentially leading to further consolidation in various sectors. As Minnesota companies capitalize on this momentum, the implications for local economies and job markets could be substantial, with increased investment and growth opportunities on the horizon. Investors and stakeholders will be closely monitoring these developments, as they may signal shifts in market dynamics and corporate strategies moving forward.

Index membership

• S&P 500 · Health Care

Related Health Care stocks

• AAgilent Technologies
• ABBVAbbVie
• ABTAbbott Laboratories
• ALGNAlign Technology
• AMGNAmgen
• BAXBaxter International
• BDXBecton Dickinson
• BIIBBiogen